Mir-142-3p target sequences reduce transgene-directed immunogenicity following intramuscular adeno-associated virus 1 vector-mediated gene delivery

Author(s):
Majowicz, A.; Maczuga, P.; Kwikkers, K.L.; Marel, S. van der; Logtenstein, R. van; Petry, H.; Deventer, S.J. van; Konstantinova, P.; Ferreira, V.
Published
2013
Publication type
Article / Letter to editor
adeno-associated virus (AAV)gene therapyimmune responsesmicroRNAmir-142-3ptransgene
Date issued
2013-06-30
Language
English
Is part of
hdl
1887/99035
doi
10.1002/jgm.2712